Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro

• Hoofdauteurs: Qinhai Ma (Auteur), Biao Lei (Auteur), Ruihan Chen (Auteur), Bin Liu (Auteur), Wencong Lu (Auteur), Haiming Jiang (Auteur), Zexing Chen (Auteur), Xiaowen Guo (Auteur), Yutao Wang (Auteur), Lu Zhang (Auteur), Qiaoyan Chen (Auteur), Xiaobo Li (Auteur), Zifeng Yang (Auteur)
• Formaat: Boek
• Gepubliceerd in: BMC, 2022-04-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Abstract Background Coronavirus disease 2019 (COVID-19) causes a global pandemic and has devastating effects around the world, however, there are no specific antiviral drugs and vaccines for the constant mutation of SARS-CoV-2. Purpose In this study, we evaluted the antiviral and anti-inflammatory a...